Clinical impact of remnant lymphatic invasion on the recurrence of esophageal squamous cell carcinoma after esophagectomy with neoadjuvant chemotherapy-Reference-Cited by-同舟云学术

Clinical impact of remnant lymphatic invasion on the recurrence of esophageal squamous cell carcinoma after esophagectomy with neoadjuvant chemotherapy

Published:2022-08-11 Issue:4 Volume:24 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Okuda Sho¹,Ohuchida Kenoki¹,Shindo Koji¹,Moriyama Taiki¹,Kawata Jun²,Tamura Koji¹,Sada Masafumi¹,Nagayoshi Kinuko¹,Mizuuchi Yusuke¹,Ikenaga Naoki¹,Nakata Kohei¹,Oda Yoshinao²,Nakamura Masafumi¹

Affiliation:

1. Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812‑8582, Japan

2. Department of Anatomic Pathology, Pathological Sciences, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812‑8582, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference46 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Comprehensive registry of esophageal cancer in Japan, 2013;Watanabe;Esophagus,2021

3. The prognostic value of residual nodal disease following neoadjuvant chemoradiation for esophageal cancer in patients with complete primary tumor response;Blackham;J Surg Oncol,2015

4. Significance of neoadjuvant downstaging in carcinoma of esophagus and gastroesophageal junction;Kamarajah;Ann Surg Oncol,2020

5. Prognostic significance of a new grading system of lymph node morphology after neoadjuvant radiochemotherapy for esophageal cancer;Bollschweiler;Ann Thorac Surg,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic impact of nodal status and lymphovascular invasion in patients undergoing neoadjuvant chemotherapy for esophageal squamous cell carcinoma;Diseases of the Esophagus;2024-05-01

2. Neoadjuvant PD-1 blockade combined with chemotherapy is not superior to neoadjuvant chemotherapy alone in resectable locally advanced esophageal carcinoma;World Journal of Surgical Oncology;2023-02-03

3. Neoadjuvant PD-1 blockade combined with chemotherapy or chemotherapy alone for patients with resectable locally advanced esophageal carcinoma: A real-world data analysis;2022-10-10